© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Immunovant, Inc. (IMVT) shows an Average True Range (ATR) of 1.34 and an Enterprise Value of 3.49B. Its average trading volume over the past 3 months is 1.82M, indicating liquidity. These fundamental metrics provide insight into IMVT's underlying financial health and market activity.
Immunovant, Inc. (IMVT) technical indicators as of December 23, 2025: the SMA 20 is 12.62%, SMA 50 at 21.03%, and SMA 200 at 55.21%. The RSI 14 value is 68.97, suggesting its current momentum. These technical analysis signals help assess IMVT's price trends and potential future movements.
Immunovant, Inc. (IMVT) stock performance overview as of December 23, 2025: The 52-week high is $27.69 (currently -0.54% below), and the 52-week low is $12.72 (currently 116.51% above). Over the past year, IMVT's performance is -0.33%, compared to the S&P 500's 10.56% change.
According to market data, Immunovant, Inc. (IMVT) stock's recent performance metrics show that over the last month, IMVT is 18.91%, with a Year-to-Date (YTD) performance of 11.18%. Over the past year, the stock has seen a -0.33% change. These figures summarize IMVT's price movements across various periods, reflecting its historical returns.
According to current financial data, IMVT stock's P/E (TTM) ratio is -10.01, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for IMVT, including P/S (N/A), P/B (8.95), and P/FCF (-10.88), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.